Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy.
about
Principles and techniques of imaging in identifying the substrate of ventricular arrhythmiaNew Imaging Technologies To Characterize Arrhythmic SubstrateLate Gadolinium Enhancement in Patients with Nonischemic Dilated Cardiomyopathy.Late gadolinium enhancement on cardiac magnetic resonance predicts adverse cardiovascular outcomes in nonischemic cardiomyopathy: a systematic review and meta-analysis.Cardiac magnetic resonance imaging for the investigation of cardiovascular disorders. Part 1: current applications.Prevalence and distribution of regional scar in dysfunctional myocardial segments in Duchenne muscular dystrophy.Hypertrophic cardiomyopathy and sudden cardiac deathNon-invasive evaluation of arrhythmic risk in dilated cardiomyopathy: From imaging to electrocardiographic measures.Applications of cardiac magnetic resonance in electrophysiology.ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.The emerging clinical role of cardiovascular magnetic resonance imaging.Feasibility of real-time magnetic resonance imaging for catheter guidance in electrophysiology studies.Cardiac involvement in patients with muscular dystrophies: magnetic resonance imaging phenotype and genotypic considerations.Role of cardiac magnetic resonance in the evaluation of dilated cardiomyopathy: diagnostic contribution and prognostic significance.Magnetic resonance-based anatomical analysis of scar-related ventricular tachycardia: implications for catheter ablation.Prevalence and clinical relevance of the morphological substrate of ventricular arrhythmias in patients without known cardiac conditions detected by cardiovascular MR.Extent of late gadolinium enhancement detected by cardiovascular magnetic resonance correlates with the inducibility of ventricular tachyarrhythmia in hypertrophic cardiomyopathy.Predictors of successful catheter ablation of ventricular arrhythmias arising from the papillary muscles.Left ventricular infarct size, peri-infarct zone, and papillary scar measurements: A comparison of high-resolution 3D and conventional 2D late gadolinium enhancement cardiac MR.Stratification of the risk of sudden death in nonischemic heart failure.An ECG index of myocardial scar enhances prediction of defibrillator shocks: an analysis of the Sudden Cardiac Death in Heart Failure TrialExploring susceptibility to atrial and ventricular arrhythmias resulting from remodeling of the passive electrical properties in the heart: a simulation approachQRS prolongation in myotonic muscular dystrophy and diffuse fibrosis on cardiac magnetic resonance.Assessment of myocardial fibrosis with cardiovascular magnetic resonance.T1 mapping of the gadolinium-enhanced myocardium: adjustment for factors affecting interpatient comparison.Quantitative assessment of artifacts on cardiac magnetic resonance imaging of patients with pacemakers and implantable cardioverter-defibrillators.Strategies for the prevention and treatment of sudden cardiac death.Myocardial fibrosis in patients with myotonic dystrophy type 1: a cardiovascular magnetic resonance studyImpact of scar, viable myocardium, and epicardial fat on substrate identification of ventricular tachycardia in a case with nonischemic cardiomyopathyMR fluoroscopy in vascular and cardiac interventions (review)New insight into scar-related ventricular tachycardia circuits in ischemic cardiomyopathy: Fat deposition after myocardial infarction on computed tomography--A pilot study.Long-term outcomes of catheter ablation of ventricular tachycardia in patients with structural heart diseaseMyocardial scarring on cardiovascular magnetic resonance in asymptomatic or minimally symptomatic patients with "pure" apical hypertrophic cardiomyopathy.Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation.Comparison of Ventricular Inducibility with Late Gadolinium Enhancement and Myocardial Inflammation in Endomyocardial Biopsy in Patients with Dilated CardiomyopathyScreening for Cardiac Magnetic Resonance Scar Features by 12-Lead ECG, in Patients with Preserved Ejection FractionT1 Mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy.Myocardial structural associations with local electrograms: a study of postinfarct ventricular tachycardia pathophysiology and magnetic resonance-based noninvasive mappingLate gadolinium enhancement among survivors of sudden cardiac arrestMRI to assess arrhythmia and cardiomyopathies: relationship to echocardiography.
P2860
Q28082235-0833FC48-E7C5-4AA7-846E-B220C5A04676Q28083928-D8BBD5AF-5986-4FC7-99A6-DE699C7ED47AQ30251600-7C94E6E3-0E2F-4BB7-9D8E-E7211E03960EQ30407667-42E09A0F-CE43-4F87-85BD-A18126A6B11EQ30432349-B38FEB8F-FCC8-49F8-B240-09637D018332Q30432693-D03617C0-C87D-4978-9F1A-D0BFE858E95DQ30433865-C2EAA243-5C5E-40AB-A167-001BD6FF7543Q30434270-FEFA7128-45B6-4D9E-A287-26B39E736AC0Q30464771-4B3D0D63-995F-47FF-A20D-AED2F3BEA92EQ30475186-BE6AC785-8299-4B22-AE09-EF8AFE27B3A1Q30475257-C512A56E-3AEE-4048-B05A-72372F7BEE15Q30493309-742364F1-F8C7-486A-B525-A395DC667742Q30498672-59EF3BDB-8E56-4A87-BCB2-6840FB6184A8Q33711320-E8C12817-C373-4ECA-B8E7-50B333F62891Q33743749-27F9E350-DA76-431D-8D7A-C6EE0F56A3E9Q33823185-172FC269-B3E8-4332-99E2-914D75FE3FB0Q33920111-5F5941C8-D09F-4C0D-A64C-3A5D601F6E4EQ34267741-3903DF2C-DA2A-4649-846A-F09DB0B8FF0FQ34309862-4A6EB763-4FD3-4CEE-B526-EBA16A1C151BQ34387880-991685EE-28F3-49F7-8DE1-6AD9F177A3FBQ34441831-53555EE1-D970-4458-85CF-0E0D71621CC9Q34495974-EAC73A54-0176-4645-86F6-49C760F4DC7DQ34554074-F1BFCE92-7AB8-4EA5-B0C8-B18603B4FFE9Q34846884-63C428EC-B0B2-46DE-89DD-5DE3ECD5C250Q34975574-F9EE66AA-8ACA-4A28-9E81-14F3F65455D2Q35555913-A30A272A-8BEC-4D44-9B5B-6EA096297269Q35560103-8B2D4665-7F6F-41C0-BB1F-89D5236E4B21Q35576188-8A3CB845-4229-4664-A544-45E418BCA443Q35643335-3CBB83E8-A088-452B-A004-2BFB01445A20Q35745598-A2D0067A-5AB8-47AE-A8F3-409A191DE736Q35798351-80F7E89E-F4BF-4E6E-AD3B-65D3EE03EE5AQ35997409-82F5F5C2-0ECC-456C-8EFB-81E9EFA88AFEQ36164284-9B9AC4BF-C926-4008-8ED1-8DC4C3A14C38Q36180655-D2048C8A-DE90-4D33-B0FB-3A3195F7CB87Q36216050-A832793F-F5D3-4099-8AEA-13ACBFDCE97AQ36385280-02CCA003-8634-46A9-9217-D67540B97481Q36417705-F29502FA-FBFA-480D-B7EB-82E595156209Q36636983-14C8A445-30D1-4959-9027-6986565D8638Q36672304-487DE63D-F8EB-457C-A0D5-96FC36C3375EQ36741535-3B93C7B0-6319-4EED-A81B-C03E05CE77E0
P2860
Magnetic resonance assessment of the substrate for inducible ventricular tachycardia in nonischemic cardiomyopathy.
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Magnetic resonance assessment ...... in nonischemic cardiomyopathy.
@ast
Magnetic resonance assessment ...... in nonischemic cardiomyopathy.
@en
Magnetic resonance assessment ...... in nonischemic cardiomyopathy.
@nl
type
label
Magnetic resonance assessment ...... in nonischemic cardiomyopathy.
@ast
Magnetic resonance assessment ...... in nonischemic cardiomyopathy.
@en
Magnetic resonance assessment ...... in nonischemic cardiomyopathy.
@nl
prefLabel
Magnetic resonance assessment ...... in nonischemic cardiomyopathy.
@ast
Magnetic resonance assessment ...... in nonischemic cardiomyopathy.
@en
Magnetic resonance assessment ...... in nonischemic cardiomyopathy.
@nl
P2093
P2860
P1433
P1476
Magnetic resonance assessment ...... in nonischemic cardiomyopathy.
@en
P2093
Albert C Lardo
Ariel Roguin
Glenn R Meininger
Gordon F Tomaselli
Henry R Halperin
João A C Lima
Menekhem M Zviman
Robert G Weiss
Ronald D Berger
Saman Nazarian
P2860
P304
P356
10.1161/CIRCULATIONAHA.105.549659
P407
P577
2005-11-01T00:00:00Z